Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Amazon.com, Inc.
WARNING LETTER
•Amazon.com, Inc.•November 14, 2023

Amazon.com, Inc. – FDA Warning Letter, Nov 14, 2023

Record Details

The FDA issued a Warning Letter to Amazon.com on November 13, 2023, regarding the distribution of several ophthalmic drug products, including "Similasan Pink Eye Relief," "The Goodbye Company Pink Eye," "Can-C Eye Drops," "Optique 1 Eye Drops," "OcluMed Eye Drops," "TRP Natural Eyes Floaters Relief," and "Manzanilla Sophia Chamomile Herbal Eye Drops."

The FDA purchased these products via Amazon's website, www.amazon.com, and determined they were introduced or delivered into interstate commerce through Amazon's Fulfillment by Amazon (FBA) service. The FDA considers these products to be drugs under section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), due to their intended use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or to affect the structure or function of the body, as evidenced by claims on their labels and labeling.

The primary violation is that these products are unapproved new drugs under section 505(a) of the FD&C Act, 21 U.S.C. 355(a), because they are not generally recognized as safe and effective (GRASE) for their intended uses and lack FDA-approved applications. The letter clarifies that homeopathic drugs are subject to the same

Company
Amazon.com, Inc.
Inspection date
November 14, 2023
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Jill P. Furman (Director)
View Company Profile

ID · 53d2c7bf-8044-4277-9dbe-62a512da52a3

Violation Codes4
21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)

Full citation text and observation details available on the Dashboard.

Other documents for Amazon.com, Inc.
  • WARNING_LETTER - 2025-04-29April 29, 2025
  • WARNING_LETTER - 2025-03-03March 3, 2025
  • WARNING_LETTER - 2024-07-30July 30, 2024
  • WARNING_LETTER - 2023-12-20December 20, 2023
  • WARNING_LETTER - 2023-08-18August 18, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Amazon.com, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.